Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy

<p>Abstract</p> <p>High expression of the inducible isoform of heme oxygenase (HO-1) is well known in various solid tumors in human and experimental animal models. To investigate the relationship between HO-1 and nasopharyngeal carcinomas, especially its involvement in the response...

Full description

Bibliographic Details
Main Authors: Fang Jun, Shi Lei
Format: Article
Language:English
Published: BMC 2008-06-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/27/1/13
id doaj-acc078be6145473e9f0e9fe28dadf297
record_format Article
spelling doaj-acc078be6145473e9f0e9fe28dadf2972020-11-24T22:16:23ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662008-06-012711310.1186/1756-9966-27-13Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapyFang JunShi Lei<p>Abstract</p> <p>High expression of the inducible isoform of heme oxygenase (HO-1) is well known in various solid tumors in human and experimental animal models. To investigate the relationship between HO-1 and nasopharyngeal carcinomas, especially its involvement in the response of nasopharyngeal carcinomas to radiotherapy, thirty-two nasopharyngeal carcinomas were semi-quantitatively analyzed by RT-PCR, and the expression of HO-1 was correlated with the consequence after novel radiotherapy, which was evaluated by the reduction of tumor size. Among 32 nasopharyngeal carcinomas, HO-1 expression was found in19 samples (59.4%), in which 9 patients (47.4%) showed no response to radiotherapy. Interestingly, in 13 nasopharyngeal carcinoma patients with negative expression of HO-1, radiotherapy exhibited to be effective (9 patients, 69.2%) or responsive (3 patients, 23.1%). In this study, we first demonstrated the expression of HO-1 in nasopharyngeal carcinomas, and more important, these findings strongly suggest the potential of HO-1as a useful index in identifying patients with well response to radiotherapy, further these data indicate a new therapeutic for nasopharyngeal carcinoma by inhibiting HO-1 activity, which warrants further investigation.</p> http://www.jeccr.com/content/27/1/13
collection DOAJ
language English
format Article
sources DOAJ
author Fang Jun
Shi Lei
spellingShingle Fang Jun
Shi Lei
Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
Journal of Experimental & Clinical Cancer Research
author_facet Fang Jun
Shi Lei
author_sort Fang Jun
title Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
title_short Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
title_full Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
title_fullStr Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
title_full_unstemmed Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
title_sort implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2008-06-01
description <p>Abstract</p> <p>High expression of the inducible isoform of heme oxygenase (HO-1) is well known in various solid tumors in human and experimental animal models. To investigate the relationship between HO-1 and nasopharyngeal carcinomas, especially its involvement in the response of nasopharyngeal carcinomas to radiotherapy, thirty-two nasopharyngeal carcinomas were semi-quantitatively analyzed by RT-PCR, and the expression of HO-1 was correlated with the consequence after novel radiotherapy, which was evaluated by the reduction of tumor size. Among 32 nasopharyngeal carcinomas, HO-1 expression was found in19 samples (59.4%), in which 9 patients (47.4%) showed no response to radiotherapy. Interestingly, in 13 nasopharyngeal carcinoma patients with negative expression of HO-1, radiotherapy exhibited to be effective (9 patients, 69.2%) or responsive (3 patients, 23.1%). In this study, we first demonstrated the expression of HO-1 in nasopharyngeal carcinomas, and more important, these findings strongly suggest the potential of HO-1as a useful index in identifying patients with well response to radiotherapy, further these data indicate a new therapeutic for nasopharyngeal carcinoma by inhibiting HO-1 activity, which warrants further investigation.</p>
url http://www.jeccr.com/content/27/1/13
work_keys_str_mv AT fangjun implicationofhemeoxygenase1inthesensitivityofnasopharyngealcarcinomastoradiotherapy
AT shilei implicationofhemeoxygenase1inthesensitivityofnasopharyngealcarcinomastoradiotherapy
_version_ 1725790186181230592